INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2025, Number 2

Cardiovasc Metab Sci 2025; 36 (2)

Diagnostic challenge: cardiac myeloid sarcoma in a patient with acute myeloid leukemia

Fernández-Rivera, Alexis Y; Vásquez-Ortiz, Zuilma Y; Galindo-Uribe, Jaime

ABSTRACT

Introduction: myeloid sarcoma, also known as granulocytic sarcoma or chloroma, is a malignant neoplasm resulting from the infiltration of immature myeloid cells into extramedullary tissues, with an estimated incidence of 2.5-9.1% in patients with acute myeloid leukemia (AML). The heart is an uncommon site of occurrence (< 1%). Currently, there are no firmly established diagnostic or treatment guidelines for this condition. Case report: a 21-year-old female patient with a history of acute myeloid leukemia (translocation 9:11), diagnosed at age 16. After receiving chemotherapy, she achieved remission in October 2019. She was referred for follow-up in December 2021, presenting with wasting syndrome, palpitations, and dyspnea (NYHA II). Conclusions: this case highlights the rarity of cardiac myeloid sarcoma and underscores the need for the use of multimodal imaging in diagnosis and follow-up. Additionally, it emphasizes the importance of establishing specialized care pathways with a cardio-onco-hematological perspective in Mexico.
  FULL TEXT PDF   FLIPBOOK

Keywords

cardiac myeloid sarcoma imaging studies cardiovascular imaging cardiac granulocytic sarcoma cardiac chloroma




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Cardioprotected spaces in Mexico: in theory a priority public health issue, but...
    2025, Vol.36, Núm. 4
  • The TG/HDL-c index, a marker of atherogenic dyslipidemia, is a significant...
    2025, Vol.36, Núm. 4
  • Initial experience with near-infrared spectroscopy in the treatment of coronary...
    2025, Vol.36, Núm. 4
  • Uncertainty and probability are the basis of clinical epidemiology
    2025, Vol.36, Núm. 4
  • Protocol for certifying stadiums in Mexico as cardio-protected spaces in the...
    2025, Vol.36, Núm. 4
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 36, Num. 2, Abril-Junio 2025. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 23 de enero de 2026.

 

2026     |     https://www.cardiovascularandmetabolicscience.org.mx/